Amyotrophic lateral sclerosis (ALS) is a progressive disorder characterized by degeneration of motor neurons in the brain and spinal cord. The onset of the disease can include clinical signs of upper (brain) motor neuron decline or more typically lower (spinal cord) motor neuron degeneration. Anatomically, patients may present with clinical signs affecting only the bulbar region (speech, swallowing, breathing), only the limbs, or both areas simultaneously. The pace of motor neuron degeneration can be accelerated, with death ensuing from paralysis and/or respiratory arrest within 3 years, or quite indolent, with patients surviving more than 10 years. The diagnosis is largely based on clinical examination with electromyography used to confirm lower motor neuron involvement and rule out other similar presentations confounding the diagnosis.
1 x 1 Brown, R.H. Jr. and Al-Chalabi, A. Amyotrophic lateral sclerosis [letter]. N Engl J Med. 2017; 377: 1602 Crossref | Scopus (0) | Google Scholar See all References
, 2 x 2 Rosenfeld, J. and Strong, M.J. Challenges in the understanding and treatment of amyotrophic lateral sclerosis/motor neuron disease. Neurotherapeutics. 2015; 12: 317–325 Crossref | Scopus (5) | Google Scholar See all References